AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 262 min read$LRCX

Lam Research Stocks Gain 4.3% Despite Citi's Target Cut

Lam Research (LRCX) shares rose 4.3% to $239.93 on October 26, despite Citi cutting its price target while maintaining a Buy rating. The company projected December-quarter revenue of $8.6 billion, with a 40.2% adjusted operating margin in September. Investors will watch for earnings growth to meet expectations.

Original reporting
finance.yahoo.com
Published Oct 26, 2026, 8:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 8:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Lam Research Stocks Gain 4.3% Despite Citi's Target Cut — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$LRCXNeutralMed
01

Why it matters

The guidance provides a concrete data point for valuation models; investors will reassess earnings expectations and target prices.

02

Market read

Guidance release is the primary catalyst for the stock's recent move and may shape short‑term trading decisions.

03

What to watch

Margin stability at 40% and potential new shipments could offset modest revenue growth.

Relevance 7/10Novelty 7/10Timing: after-hours today

Background

Lam Research's stock rose 4.27% on the day, while Citi cut its price target, highlighting a divergence between market sentiment and analyst outlook.

Company-level read

Ticker impact

$LRCXNeutralMedium confidence
Context

Lam Research disclosed its December-quarter revenue guidance of $8.6 billion ± $400 million, the first report of this guidance.

Expected impact

potential pressure as investors weigh modest growth versus high expectations

Evidence & confidence

The new revenue range is only a 4‑5% sequential increase, which could be seen as a slowdown after strong prior results, likely limiting upside.

Market effects

Sector

Chip‑equipment sector may see heightened scrutiny of growth forecasts after this guidance.

Regional

U.S. semiconductor stocks could experience modest pullback in the afternoon session.

Global

Limited to investors tracking semiconductor equipment makers worldwide.

Counterpoint

What could challenge this read

The rally suggests the market may already price in stronger growth, so the guidance could be a buying opportunity if demand remains robust.

Key entities

  • company
    Lam Research

    Semiconductor equipment supplier reporting December-quarter revenue guidance.

Read at source← All news

Related articles

OCT 27
$LRCXMed

Lam Research Stock Is 45% Below Its High. How Deep Have Past Drops Gone?

Lam Research (LRCX) shares have fallen 45.1% from their June 30 high, despite reporting record revenue. Historically, the stock has declined more than the S&P 500 during market shocks, with an average drop of 22.8%. The company's operating margin is at a 40-quarter high, and it holds $7.44 billion in cash. Management cited supply chain constraints for a cautious revenue forecast.

finance.yahoo.com3 min
OCT 27
$LRCXMedAI 8/10

Tech Sell-Off: This All-Star Artificial Intelligence Stock Is Down 50% but Up 127,300% Since Its IPO. Here's Why It's a Screaming Buy Heading Into the Midterms.

Lam Research (LRCX) stock is down 50% from its June high but up 127,300% since its 1984 IPO. The semiconductor equipment maker reported record Q3 revenue of $8.22B and EPS of $2.20, beating estimates. Despite strong results, the stock fell due to 'light' guidance of $8.6B revenue and $2.33 EPS for Q4, attributed to supply constraints. Management forecasts industrywide wafer front-end equipment spending to exceed $200B by 2027, with Lam expected to grow faster than the industry.

finance.yahoo.com3 min
OCT 25
$METAMedAI 8/10

Does enough capital exist to finance everyone’s ambitious AI spending plans?

Meta reported a 26% revenue increase to $64.6B, but negative free cash flow of -$2.1B. The company raised its 2026 capital spending forecast to $135B-$145B and announced new non-voting shares. Executives from Broadcom, BlackRock, and Nvidia expressed concerns about capital scarcity for AI development. AI-linked stocks like Nvidia, CoreWeave, and Lam Research fell, while broader market indices showed mixed performance. Treasury yields also declined.

investing.com3 min
OCT 24
$AAPLMed

5 big analyst AI moves: ’Uniquely catalyst-rich’ months ahead for SpaceX

Loop Capital downgraded Apple to Hold, cutting its price target to $330 and lowering iPhone revenue forecasts. JPMorgan upgraded Intel to Neutral, citing balanced risk-reward. Citi initiated a positive Catalyst Watch on SpaceX, highlighting upcoming catalysts. Mizuho reiterated Outperform on Lam Research, recommending buying on pullback. Yardeni Research noted an AI bubble but said it's not yet close to bursting.

investing.com3 min
OCT 24
$LRCXHighAI 8/10

The Pareto Investor (@paretoinvestor)

Lam Research reported record revenue of $8.22B, beating estimates, but its CFO cited supply chain constraints for lower-than-expected guidance. Shares fell 11%, and other chip-related stocks like Nvidia, Qualcomm, Marvell, Intel, Applied Materials, and ASML also declined. The downturn reflects broader chip sector volatility and supply chain concerns.

substack.com2 min
OCT 24
$LRCXMed

Lam Says U.S. Export Rules Limit China Revenue as Share Rebounds to 35%

Lam Research reported that U.S. export rules have reduced its China revenue, which accounted for 35% of its $8.27 billion in sales for the quarter ended Sept. 27. This is up from 26% in June but down from 43% in the same period last year. The company warned that the impact of these rules could increase, affecting its future revenue. Lam projected revenue of $8.6 billion for the next quarter.

econotimes.com2 min